Eichler HG - Search Results

1

Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?

Eichler HG, Bloechl-Daum B, Broich K, Kyrle PA, Oderkirk J, Rasi G, Santos Ivo R, Schuurman A, Senderovitz T, Slawomirski L, Wenzl M, Paris V. Eichler HG, et al. Clin Pharmacol Ther. 2019 Apr;105(4):912-922. doi: 10.1002/cpt.1226. Epub 2018 Oct 14. Clin Pharmacol Ther. 2019. PMID: 30178490 Free PMC article.

2

Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation.

Eichler HG, Koenig F, Arlett P, Enzmann H, Humphreys A, Pétavy F, Schwarzer-Daum B, Sepodes B, Vamvakas S, Rasi G. Eichler HG, et al. Clin Pharmacol Ther. 2020 Apr;107(4):773-779. doi: 10.1002/cpt.1638. Epub 2019 Oct 1. Clin Pharmacol Ther. 2020. PMID: 31574163 Free PMC article. Review.

3

Clinical trial publications: A sufficient basis for healthcare decisions?

Eichler HG, Rasi G. Eichler HG, et al. Eur J Intern Med. 2020 Jan;71:13-14. doi: 10.1016/j.ejim.2019.11.022. Epub 2020 Jan 14. Eur J Intern Med. 2020. PMID: 31948774 No abstract available.

4

Clinical Trials for COVID-19: Can we Better Use the Short Window of Opportunity?

Eichler HG, Cavaleri M, Enzmann H, Scotti F, Sepodes B, Sweeney F, Vamvakas S, Rasi G. Eichler HG, et al. Clin Pharmacol Ther. 2020 Oct;108(4):730-733. doi: 10.1002/cpt.1891. Epub 2020 Jun 12. Clin Pharmacol Ther. 2020. PMID: 32407539 Free PMC article. Review.

5

Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth.

Eichler HG, Pignatti F, Schwarzer-Daum B, Hidalgo-Simon A, Eichler I, Arlett P, Humphreys A, Vamvakas S, Brun N, Rasi G. Eichler HG, et al. Among authors: eichler i. Clin Pharmacol Ther. 2021 May;109(5):1212-1218. doi: 10.1002/cpt.2083. Epub 2020 Nov 12. Clin Pharmacol Ther. 2021. PMID: 33063841 Free PMC article. Review.

6

Open clinical trial data for all? A view from regulators.

Eichler HG, Abadie E, Breckenridge A, Leufkens H, Rasi G. Eichler HG, et al. PLoS Med. 2012;9(4):e1001202. doi: 10.1371/journal.pmed.1001202. Epub 2012 Apr 10. PLoS Med. 2012. PMID: 22505851 Free PMC article.

7

Drug policy for an aging population--the European Medicines Agency's geriatric medicines strategy.

Cerreta F, Eichler HG, Rasi G. Cerreta F, et al. Among authors: eichler hg. N Engl J Med. 2012 Nov 22;367(21):1972-4. doi: 10.1056/NEJMp1209034. N Engl J Med. 2012. PMID: 23171092 No abstract available.

8

Access to patient-level trial data--a boon to drug developers.

Eichler HG, Pétavy F, Pignatti F, Rasi G. Eichler HG, et al. N Engl J Med. 2013 Oct 24;369(17):1577-9. doi: 10.1056/NEJMp1310771. Epub 2013 Oct 21. N Engl J Med. 2013. PMID: 24144395 Free article. No abstract available.

9

Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.

Eichler HG, Adams R, Andreassen E, Arlett P, van de Casteele M, Chapman SJ, Goettsch WG, Martinsson JL, Llinares-Garcia J, Nachtnebel A, Pean E, Rasi G, Reksten TR, Timmers L, Vreman RA, van de Vijver I, Wenzl M. Eichler HG, et al. Int J Technol Assess Health Care. 2021 Aug 23;37(1):e83. doi: 10.1017/S026646232100057X. Int J Technol Assess Health Care. 2021. PMID: 34424152

10

Drug Regulation and Pricing--Can Regulators Influence Affordability?

Eichler HG, Hurts H, Broich K, Rasi G. Eichler HG, et al. N Engl J Med. 2016 May 12;374(19):1807-9. doi: 10.1056/NEJMp1601294. N Engl J Med. 2016. PMID: 27168431 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters